The Cedars-Sinai Blood and Marrow Transplant Program continually monitors the care provided to patients who receive blood and marrow transplants. The results of this commitment to measuring the quality of patient care are reflected in the tables below.
Number of Blood & Marrow Transplants Performed Annually
Evidence indicates that medical centers that do more of a specific procedure tend to have better patient outcomes. The types and volumes of blood and marrow transplants done at Cedars-Sinai are summarized in the chart below:
|Types and Volumes of Blood and Marrow Transplants Performed at Cedars-Sinai Medical Center||2011||2012||2013|
|Autologous transplants: These are blood and marrow transplants in which stem cells are taken from the patient before chemotherapy or radiation. These cells are infused for the transplant.||83||91||81|
|Allogeneic transplants, Matched Related Donor: These are blood and marrow transplants in which a patient receives stem cells from a relative after having chemotherapy or radiation||18||35||15|
|Allogeneic transplants, Matched Unrelated Donor: These are blood and marrow transplants in which a patient receives stem cells from an unrelated donor or donated umbilical cord after having chemotherapy or radiation||18||24||27|
Blood and Marrow Transplant Survival Rates
The BMT survival rates measures the percentage of patients who have received stem cell transplants who have survived over a specified period of time. Survival outcomes is measured for both autologous and allogeneic transplants. Allogeneic transplants carry a greater level of risk than autologous transplants. This patient data is carefully analyzed by our medical staff and submitted to the Center for International Blood and Marrow Transplant Research, the CIBMTR. Cedars-Sinai is also committed to examining our high volume autologous patient population and our analysis demonstrates excellent outcomes.
For view the survival data, please click on the hyperlinks below.